Literature DB >> 8811171

Changes in agalactosyl IgG levels correlate with radiological progression in early rheumatoid arthritis.

J K Lacki1, W Porawska, U Mackiewicz, S Mackiewicz, W Müller.   

Abstract

Immunoglobulin G-lacking galactose (Gal[0]) appears to be helpful in differential diagnosis of early synovitis, and correlates with disease activity in rheumatoid arthritis (RA). Its utility for RA monitoring and prognosis has been evaluated in the present study. Forty-eight patients with early RA were observed for 3 years. Hand radiographs were assessed according to Larsen and results were expressed as damage score (DS) and progression of damage score (PDS). Gal[0], DS, and PDS were evaluated at the onset of the study and after 1 and 3 years. The average values of Gal[0] in RA patients at the onset of the observation were significantly higher as compared to healthy controls (0.43 +/- 0.22 vs. -0.03 +/- 0.09, P < 0.05). The findings of Gal[0] after a 3-year follow-up were also higher as compared to healthy controls (0.37 +/- 0.21 vs. -0.03 +/- 0.09, P < 0.05). Radiological progression (PDS > 15) was observed in 16 patients. This group was characterized by a constantly high level of Gal[0]. The level of Gal[0] in patients without or with moderate radiological progression (PDS < 15) was significantly lower at the onset of the study and remained low during the observation. The relationship between Gal[0] and radiological progression was shown. The data thus far obtained suggest that Gal[0] may serve as an indicator for the disease course in patients with RA. Secondly, we cannot exclude the possibility that the constantly elevated level of Gal[0] causes erosions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8811171     DOI: 10.3109/07853899609033129

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  9 in total

1.  The changes in monosaccharide composition of immunoglobulin G in the course of rheumatoid arthritis.

Authors:  Ewa Gindzienska-Sieskiewicz; Piotr Adrian Klimiuk; Dariusz Gabriel Kisiel; Andrzej Gindzienski; Stanislaw Sierakowski
Journal:  Clin Rheumatol       Date:  2006-08-04       Impact factor: 2.980

2.  Glycosylation in Autoimmune Diseases.

Authors:  Marta Ząbczyńska; Paweł Link-Lenczowski; Ewa Pocheć
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

Review 3.  Immunoglobulin G N-glycan Biomarkers for Autoimmune Diseases: Current State and a Glycoinformatics Perspective.

Authors:  Konstantinos Flevaris; Cleo Kontoravdi
Journal:  Int J Mol Sci       Date:  2022-05-06       Impact factor: 6.208

Review 4.  The association between rheumatoid arthritis and periodontal disease.

Authors:  Jacqueline Detert; Nicole Pischon; Gerd R Burmester; Frank Buttgereit
Journal:  Arthritis Res Ther       Date:  2010-10-22       Impact factor: 5.156

5.  Anti-agalactosyl IgG antibodies in Thai patients with rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis.

Authors:  Worawit Louthrenoo; Nuntana Kasitanon; Ramjai Wichainun; Suparaporn Wangkaew; Waraporn Sukitawut; Shoji Kuwata; Fujio Takeuchi
Journal:  Clin Rheumatol       Date:  2009-11-29       Impact factor: 2.980

Review 6.  [Pathogenesis of parodontitis in rheumatic diseases].

Authors:  J Detert; N Pischon; G-R Burmester; F Buttgereit
Journal:  Z Rheumatol       Date:  2010-03       Impact factor: 1.372

Review 7.  Rheumatoid Arthritis in the View of Osteoimmunology.

Authors:  Mélanie Auréal; Irma Machuca-Gayet; Fabienne Coury
Journal:  Biomolecules       Date:  2020-12-31

Review 8.  Host and bacterial factors linking periodontitis and rheumatoid arthritis.

Authors:  Anna Krutyhołowa; Karolina Strzelec; Agata Dziedzic; Grzegorz P Bereta; Katarzyna Łazarz-Bartyzel; Jan Potempa; Katarzyna Gawron
Journal:  Front Immunol       Date:  2022-08-25       Impact factor: 8.786

9.  Variations in oral microbiome profiles in rheumatoid arthritis and osteoarthritis with potential biomarkers for arthritis screening.

Authors:  Bin Chen; Yan Zhao; Shufeng Li; Lanxiu Yang; Haiying Wang; Tao Wang; Zhongtao Gai; Xueyuan Heng; Chunling Zhang; Junjie Yang; Lei Zhang
Journal:  Sci Rep       Date:  2018-11-20       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.